Cambridgeshire, United Kingdom

Jesús Zurdo

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Cambridgeshire, GB (2021 - 2023)
  • Cambridge, GB (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Jesús Zurdo in Antibody and CRISPR Technology

Introduction

Jesús Zurdo is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the fields of biotechnology and genetic engineering. With a total of 3 patents, his work focuses on enhancing therapeutic agents and reducing immunogenicity in CRISPR-associated proteins.

Latest Patents

One of his latest patents involves CL and/or CH1 mutated antibodies for drug conjugation. This invention describes antibodies with modified constant regions that allow for conjugation to therapeutic payloads. Preferred antibodies include a mutation at light chain position 180, with options for residues such as C, K, Q, or non-natural amino acids. Additional mutations may also be combined with the mutation at position 180, including various positions on both light and heavy chains.

Another significant patent relates to CRISPR-associated (Cas) proteins with reduced immunogenicity. This invention outlines methods to decrease the immunogenicity of Cas proteins, which are crucial for cell and gene therapy. The methods described include genetic modifications and alterations of gene expression using these modified Cas proteins, both in-vivo and ex-vivo.

Career Highlights

Jesús Zurdo is currently employed at Lonza Inc., where he continues to innovate in the field of biotechnology. His work has the potential to impact therapeutic development significantly.

Collaborations

He collaborates with notable colleagues such as Ramon Gomez De La Cuesta and Lars Arne Andreas Arnell, contributing to a dynamic research environment.

Conclusion

Jesús Zurdo's innovative work in antibody technology and CRISPR systems showcases his commitment to advancing biotechnology. His patents reflect a deep understanding of molecular modifications that can lead to improved therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…